National Kidney Foundation Statement on Omnibus Spending Bill

On April 30th, U.S. Congressional leaders reached a bipartisan agreement on a larger omnibus spending bill to fund federal agencies and programs through the remainder of FY 2017, ending on Sep. 30, 2017.  The final vote in both Houses will occur by the end of this week.  
Overall, the priorities of the National Kidney Foundation fared well. Specifically, the omnibus spending bill includes funding for the Centers for Disease Control and Prevention (CDC) Chronic Kidney Disease Program, $2,100,000, which was the level funded from FY 2016 and will be used for disease surveillance and detection; National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health, $1,870,595,000 which represents an increase of $52,238,000 and will be used for kidney disease research; and the Health Resources and Services Administration Organ Transplantation, $23,549,000, which is the same level funded from FY 2016 and will be used for donor wait list and donor awareness programs.
National Kidney Foundation sincerely appreciates the Congressional Appropriations leadership and the House and Senate Majority and Minority leadership for their efforts to advance and protect the needs of people with kidney disease. 
Kidney Disease Facts
1 in 3 American adults is at risk for kidney disease.  26 million American adults have kidney disease—and most aren’t aware of it.  Risk factors for kidney disease include diabetes, high blood pressure, family history, and age 60+.  People of African American; Hispanic; Native American; Asian; or Pacific Islander descent are at increased risk for developing the disease.  African Americans are 3 ½ times more likely, and Hispanics 1 ½ times more likely, to experience kidney failure.

The National Kidney Foundation (NKF) is the largest, most comprehensive and longstanding organization dedicated to the awareness, prevention and treatment of kidney disease.  For more information about the NKF visit